253
Participants
Start Date
June 30, 2005
Primary Completion Date
June 30, 2007
Study Completion Date
March 31, 2010
Birch pollen allergoid
Subcutaneous injections were applied in the upper arm. Vials with three different concentrations were used: Strength A (1000 TU/mL), strength B (10 000 TU/mL) and strength 0 (100 TU/mL) by dilution of strength A.
Placebo
Sterile aluminium hydroxide suspension for subcutaneous injection were applied in the upper arm. Vials with strength A contained 0.0125 mg/mL and with strength B 0.125 mg/mL histamine-dihydrochloride and strength 0 was produced by dilution of strength A. The vials containing the placebo solution were identical in their outer appearance with the active study preparation of the birch pollen allergoids.
Allergopharma Joachim Ganzer KG, Reinbek
Allergopharma GmbH & Co. KG
INDUSTRY